Apheresis platelets transfusion from a COVID-19 positive donor in a
hematopoietic stem cell transplantation patient-- case report
Abstract
Coronavirus pandemic is the present concern worldwide. The virus is
transmitted via a droplet route; however, transmission through blood
products had not been reported. We present a 22-month-old boy with
leukemia who developed fever and liver veno-occlusive disease 22 days
post allogeneic hematopoietic stem cell transplantation coincidently
after receiving apheresis platelets from a donor who tested positive for
COVID-19 shortly after donation. The patient’s nasal swab and blood PCRs
remained negative two weeks after the event. Although this case did not
show viral transmission through platelet transfusion, objective donor
screening and viral deactivating techniques are practical options to
ensure safety.